Vaxil BioTherapeutics vaxilbio.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Vaxil BioTherapeutics is a biotechnology firm focused on cancer treatments. Years of research have culminated in a significant cancer immunotherapy vaccine platform including a lead cancer vaccine candidate, Immucin, which was identified, developed, and most recently tested in a Phase-I/II clinical trial with 15 cancer patients. Vaxil has published its research in a variety of the world's top medical journals, and the Company is rapidly advancing its targeted cancer immunotherapy technologies.

Vaxil BioTherapeutics is a biotechnology firm focused on cancer treatments. Years of research have culminated in a significant cancer immunotherapy vaccine platform including a lead cancer vaccine candidate, Immucin, which was identified, developed, ...Show all

Company (IPO / Went public)

Phone:

Fax:



Rehovot,
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Vaxil BioTherapeutics $0M Mar 10, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Vaxil BioTherapeutics Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antibodies directed against signal peptides, methods and uses thereof Sep 13, 2012 Aug 15, 2017 Patent
Antigen specific multi epitope-based anti-infective vaccines Jul 15, 2010 May 09, 2017 Patent
Antigen specific multi epitope vaccines Sep 23, 2007 Nov 08, 2016 Patent
Antigen specific multi epitope-based anti-infective vaccines May 08, 2017 Application
Antigen specific multi epitope vaccines Nov 07, 2016 Application